CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

UK regulator halts sales of Tavneos; UniQure seeks approval for Huntington's gene therapy

RegulatoryrejectedTavneosZiiheraNegative
AI Analysis

Summary

The UK's MHRA has halted sales of Tavneos, following similar action by the EMA. UniQure is seeking approval for a Huntington's disease gene therapy.

Outcome Details

UK regulator (MHRA) halted sales of Tavneos following EMA action

Importance:7/10
Sentiment:
-0.80
regulatory_actionsales_haltgene_therapyHuntington's_disease
Related Companies
$QURE$REGN$JAZZ$BMRN$ASND$AZN$HMDCF

Read the original article

Published by Endpoints News on September 2, 2026 3:07 PM

Read Original